Metropolitan Life Insurance Company (MetLife)’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,203
| Closed | -$15.4K | – | 1603 |
|
|
2024
Q1 | $15.4K | Hold |
2,203
| – | – | ﹤0.01% | 1976 |
|
|
2023
Q4 | $19.5K | Hold |
2,203
| – | – | ﹤0.01% | 1933 |
|
|
2023
Q3 | $21K | Hold |
2,203
| – | – | ﹤0.01% | 1870 |
|
|
2023
Q2 | $32.3K | Buy |
2,203
+1,485
| +207% | +$21.8K | ﹤0.01% | 1677 |
|
|
2023
Q1 | $8.83K | Hold |
718
| – | – | ﹤0.01% | 2199 |
|
|
2022
Q4 | $13.3K | Buy |
+718
| New | +$13.3K | ﹤0.01% | 2180 |
|